Author

P. Wijten

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

A. de la Fuente· 1 shared H. Abbas· 1 shared M. Al-Motawa· 1 shared M. Xue· 1 shared N. Rabbani· 1 shared P. Thornalley· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. de la Fuente

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity -- opportunity for repurposed chemotherapy of COVID-19 infection

M. Al-Motawa, H. Abbas, P. Wijten, A. de la Fuente, M. Xue, N. Rabbani, P. Thornalley

This paper identifies SARS-CoV-2 vulnerability to methylglyoxal and suggests repurposing doxorubicin and paclitaxel for COVID-19 treatment based on their ability to increase cellular methylglyoxal levels.

bioRxiv · Apr 7, 2020Biochemistry